Familial Chylomicronemia Syndrome (FCS)

This program offers complimentary genetic testing for patients in the U.S. or Canada with severe refractory hypertriglyceridemia, defined as two or more fasting triglyceride levels >880 mg/dL (10 mmol/L) without secondary causes. Testing evaluates genetic contributors to FCS and related disorders, enabling more accurate diagnosis of persistent sHTG. Pre- and post-test genetic counseling through Genome Medical is included at no cost.

Sponsored, no-charge FCSNext panel for suspected monogenic hypertriglyceridemia/FCS (e.g., extreme TGs, recurrent pancreatitis, early onset, therapy-refractory). Order through Ambry; clinical report supports diagnosis, management decisions, and cascade testing of at-risk relatives.